研究人員呼籲採用針對阿茲海默症的新型多系統治療方法
Researchers Call for New Multi-System Approach to Alzheimer's Treatment
數十年來，阿茲海默症的研究一直由尋找「特效藥」(ㄊㄜˋㄒㄧㄠˋㄧㄠˋ)——一種能清除類澱粉蛋白斑塊的單一藥物——所主導。
For decades, Alzheimer’s research was dominated by the search for a “silver bullet”—a single drug to clear away amyloid plaques.
科學家們現在正轉向一種全新的多系統取徑，將阿茲海默症視為一種複雜且具備多重面向的病症。
Scientists are now moving toward a new multi-system approach, viewing Alzheimer’s as a complex, multifaceted condition.
研究人員不再只針對單一蛋白質，而是整合基因組學、代謝與發炎數據，將大腦視為一個相互連結的生物網絡。
Instead of targeting one protein, researchers are integrating genomics, metabolism, and inflammation data to treat the brain as an interconnected biological network.
這種轉變利用先進的 AI 分析海量數據集，而實驗室培養的迷你大腦則允許測試能同時處理多種路徑的療法。
This shift uses advanced AI to analyze massive datasets, while lab-grown mini-brains allow for testing therapies that address multiple pathways simultaneously.
透過專注於整體健康與藉由生物標記進行早期檢測，專家們希望能超越單純的症狀管理。
By focusing on systemic health and early detection through biomarkers, experts hope to move beyond simple symptom management.
這種整合策略標誌著簡單解決方案時代的終結，並提供了一條更務實的疾病改善途徑，重點在於病人的整體健康而非孤立的大腦標記。
This integrated strategy marks the end of the era of simple solutions and offers a more realistic path toward disease modification, focusing on the patient's overall health rather than isolated brain markers.
